BioCentury
ARTICLE | Financial News

Evonetix raises $12.3M series A

February 2, 2018 8:16 PM UTC

Synthetic biology company Evonetix Ltd. (Little Chesterford, U.K.) raised $12.3 million on Jan. 30 in a series A round co-led by new investors DCVC and Draper Esprit. New investor Morningside and existing investors Providence Investment, Cambridge Consultants, Rising Tide Fund and Civilization Ventures also participated...

BCIQ Company Profiles

Evonetix Ltd.